Dexamethasone controlled-release implant - pSividaAlternative Names: Dexamethasone sustained-release - pSivida
Latest Information Update: 16 Nov 2016
At a glance
- Originator pSivida
- Developer Hospital for Special Surgery; pSivida
- Class Anti-inflammatories; Antiemetics; Antineoplastics; Corticosteroids; Fluorinated steroids; Glucocorticoids; Pregnadienetriols; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Osteoarthritis